Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Depress Anxiety ; 28(12): 1081-5, 2011 Dec 21.
Article in English | MEDLINE | ID: mdl-22065550

ABSTRACT

BACKGROUND: Women are at an increased risk of depression and other mental health problems following rape. Various etiological factors for depression, including predisposing genetic factors, have been identified. Telomeres are repetitive nucleoprotein structures located at chromosomal ends that protect them from premature degradation. Telomeres reduce in length with each cell division, resulting in cellular senescence and apoptosis. METHODS: Relative quantification of telomeric repeats using qPCR was performed to investigate whether shorter relative leukocyte telomere length (LTL) in a cohort of 64 rape victims was associated with resilience, the development of rape trauma-related major depressive disorder (MDD) or the development of posttraumatic stress disorder (PTSD) after 3 months. RESULTS: Out of the 64 participants, 23 participants were diagnosed with MDD at baseline and 31 after 3 months. Nine participants were diagnosed with PTSD (MDD and PTSD specifically related to the trauma). No significant associations were observed between relative LTL and resilience or the development of MDD at either baseline or after 3 months in this cohort. However, a marginally significant association was evident between relative LTL and PTSD status. CONCLUSIONS: The significant association between relative LTL and PTSD suggests that shorter relative LTL might have acted as a predisposing factor in the development of PTSD after a severely traumatic event. The results of this study indicate that telomere shortening may be an important marker of PTSD risk, with implications for early intervention and timely treatment, and as such warrant replication in a larger cohort.


Subject(s)
Depressive Disorder, Major/etiology , Rape/psychology , Stress Disorders, Post-Traumatic/etiology , Telomere/metabolism , Adolescent , Adult , Depressive Disorder, Major/genetics , Depressive Disorder, Major/pathology , Female , Humans , Leukocytes/metabolism , Leukocytes/pathology , Polymerase Chain Reaction , Stress Disorders, Post-Traumatic/genetics , Young Adult
2.
Pharmacogenomics ; 11(8): 1095-103, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20712527

ABSTRACT

AIMS: This study was aimed at elucidating the common sequence variation present in the CYP2C19 gene within the South African Xhosa population and comparing it with the Cape Mixed Ancestry (CMA) population for possible future pharmacogenetic applications. MATERIALS & METHODS: Common sequence variation was identified through the resequencing of 15 Xhosa individuals. The detected variants were prioritized for genotyping in an additional 85 Xhosa and 75 CMA individuals, while 5 -upstream variants were analyzed using dual luciferase reporter assays. RESULTS: Resequencing of the Xhosa population revealed 30 variants, including the novel CYP2C19*27 and CYP2C19*28 alleles. CYP2C19*27, characterized by -1041G>A, caused a twofold decrease in luciferase activity, while CYP2C19*28 is characterized by the nonsynonymous V374I variant. In addition, the previously characterized variants, CYP2C19*2, CYP2C19*9 and CYP2C19*17, were present in both populations, while CYP2C19*3 was only observed in the CMA population. CONCLUSION: Our data demonstrate that both the Xhosa and CMA populations exhibit unique genetic profiles that could influence the outcome of drug therapy in these populations.


Subject(s)
Aryl Hydrocarbon Hydroxylases/genetics , Black People/genetics , Pharmacogenetics/methods , Polymorphism, Single Nucleotide , Base Sequence , Cell Line, Tumor , Cohort Studies , Cytochrome P-450 CYP2C19 , Genes, Reporter , Genotype , Humans , Luciferases/genetics , Metabolic Detoxication, Phase I/genetics , Molecular Sequence Data , Plasmids , Polymerase Chain Reaction , South Africa , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...